Catalyst Wire Dossier Catalyst Wire Dossier

TMC (topotecan, cyclophosphamide and melphalan)

topotecan, cyclophosphamide, and melphalan
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TMC (topotecan, cyclophosphamide and melphalan), covering 2018-11-07 to 2018-11-07. Get the full timeline:

Most recent: Clinical Trial Update: TMC (Topotecan, Cyclophosphamide and Melphalan) for Multiple Myeloma [Phase 2]

See pricing